At a glance
ClinicalIndex Comparison RecordN/ACompleted· 1,041 enrolled
Drug / intervention
MitraClip NTR/XTR Systemdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Contemporary, Prospective Study Evaluating Real-world Experience of Performance and Safety for the Next Generation of MitraClip® Devices (EXPAND)
In Brief
An observational study evaluating MitraClip NTR/XTR System for Mitral Valve Regurgitation and Mitral Regurgitation. Completed, enrolled 1,041 participants across 57 sites in 8 countries.
Detailed Summary
The MitraClip EXPAND Study (A Contemporary, Prospective Study Evaluating Real-world Experience of Performance and Safety for the Next Generation of MitraClip Devices) is designed to confirm the safety and performance of the MitraClip NTR System and MitraClip XTR System.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsMitral Valve Regurgitation, Mitral Regurgitation
CountriesGermany, Israel, Italy, Netherlands, Spain, Switzerland, United Kingdom, United States
CollaboratorsAbbott
Timeline
N/ACompletedFinished
20192020202120222023202420252026
First PostedApr 2018
Enrollment StartApr 2018
Primary CompletionApr 2019
Study CompletionDec 2020
TodayJul 2026
First PostedApr 19, 2018
Enrollment StartApr 26, 2018
Primary CompletionApr 5, 2019
Study CompletionDec 31, 2020
TodayJul 2, 2026
Enrollment to primary: 11 monthsPosted 8.2 years ago
Interventions
MitraClip NTR/XTR Systemdevice
Percutaneous mitral valve repair using the MitraClip NTR/XTR system.